Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects Higher-Grade in Both Cleary and WOW Zones at Golden Summit (click to learn more) Lancaster Secures Premier Gold Project in Australia's Most Productive Mining Belts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News BioNxt Solutions Inc C.BNXT

Alternate Symbol(s):  BNXTF

Healthcare Biotechnology
BioNxt Solutions Inc. is a bioscience company. The Company is focused on drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical ingredient investment opportunities, including precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health screening tests; and standardization of emerging active... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (CSE:BNXT)

BioNxt Solutions Prepares for Human Bioequivalence Study For MS

ACCESS Newswire 1 day ago

BioNxt Solutions Announces Closing of Final Tranche of Fully Subscribed Convertible Debenture Unit Private Placement

ACCESS Newswire March 14, 2025

BioNxt Solutions Announces Closing of First Tranche of Convertible Debenture Unit Private Placement

ACCESS Newswire February 28, 2025

BioNxt Solutions Announces Debenture Unit Financing

ACCESS Newswire February 24, 2025

Clarification of Promotional Activities

ACCESS Newswire February 21, 2025

BioNxt Solutions Unveils Accelerated 90-Day Plan: Global Patent Advancements, MS Clinical Trial, and Anti-Aging Expansion

ACCESS Newswire February 19, 2025

BioNxt Accelerates R&D with Move to Gen-Plus Laboratory in Munich, Germany, Expanding Drug Delivery Research Capabilities

ACCESS Newswire January 21, 2025

BioNxt Solutions Expands Patent Protection for Drug Delivery Innovations Backed by Positive IPRP

ACCESS Newswire December 19, 2024

BioNxt Solutions Reports Progress on BNT23001 Development for Multiple Sclerosis Treatment

ACCESS Newswire December 9, 2024
View More News ››

Opinion & Analysis (CSE:BNXT)

XPhyto: Buyouts, Biosensors and a Booming Business

Stockhouse Editorial August 4, 2021

XPhyto: Proof of Concept for Mescalin Synthesis

Stockhouse Editorial June 10, 2021

XPhyto Therapeutics: Are they Selling the Solution to Germany’s Rapid Testing Crisis?

Stockhouse Editorial June 3, 2021

A Life Sciences Project Accelerator Kicks into High Gear

Stockhouse Editorial May 11, 2021

XPhyto: Why Rapid PCR Testing is Here to Stay

Stockhouse Editorial April 23, 2021

XPhyto: Is Mescaline the Next Big Mood-Modifying Medicine?

Stockhouse Editorial April 6, 2021
View More Opinion ››

Bullboard Posts (CSE:BNXT)

Spellbinding News!

CSE:BNXT - BioNxt Solutions Prepares for Human Bioequivalence Study For Multiple Sclerosis (MS) https://bionxt.com/bionxt-solutions...
Skyrocket666 - 18 hours ago

The calm before the storm

Been eerily quiet but BNXT has held strong during the tumultuous past few weeks and seems to be rebuilding strength ready to resume its...
Skyrocket666 - 8 days ago

Rolling on!

https://www.kapitalerhoehungen.de/kommentare/bayer-bionxt-solutions-evotec-falscher-zoll-alarm-bei-pharma-und-biotech-welche-aktien...
Skyrocket666 - April 8, 2025

RE:Improving health outcomes worldwide through ease of use!

"active pharmaceutical ingredients are applied to patches that dissolve in the mouth under the tongue," Is this your wording...
Pandora - April 3, 2025

Improving health outcomes worldwide through ease of use!

BioNxt Solutions: Fresh capital for innovative healthcare solutions The Canadian biotech company BioNxt Solutions is driving the...
Skyrocket666 - April 3, 2025

BNXT featured in financial news article

Novo Nordisk, BioNxt Solutions, Bayer: Three ways to health and returns BioNxt Solutions: Fresh capital for innovative healthcare...
Skyrocket666 - April 3, 2025
View more Bullboard ››

AJA Health and Wellness Inc.

AJA Health and Wellness Inc.

AJA Health and Wellness Inc. is an India-based health and wellness company. The Company operates through its subsidiaries ...
View More »